UCSF

ZINC01530639

Substance Information

In ZINC since Heavy atoms Benign functionality
October 6th, 2004 30 Yes

CAS Numbers: 155229-76-8 , 93957-54-1 , 93957-55-2

Other Names:

(+)-(3R,5S)-fluvastatin

(-)-(3S,5R)-fluvastatin

(-)-(3S,5R)-fluvastatin(1-); (-)-fluvastatin(1-); (3S,5R)-(-)-fluvastatin(1-)

(-)-(3S,5R)-fluvastatin; (3S,5R)-(-)-fluvastatin; (3S,5R,6E)-7-[3-(4-fluorophenyl)-1-isopropyl-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid

(3R,5R,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid

(3R,5R,6E)-7-[3-(4-fluorophenyl)-1-isopropyl-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid

(3R,5S)-7-[3-(4-fluorophenyl)-1-propan-2-ylindol-2-yl]-3,5-dihydroxyhept-6-enoic acid

(3R,5S,6E)-7-[3-(4-fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid

(3R,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid

(3R,5S,6E)-7-[3-(4-fluorophenyl)-1-isopropyl-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid

(3R,5S,6E)-rel-7-[3-(4-Fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl]-3,5-dihydroxy-6-heptenoic acid

(3S,5R)-7-(3-(4-fluorophenyl)-1-isopropyl-1H-indol-2-yl)-3,5-dihydroxyhept-6-enoic acid sodium salt

(3S,5R)-fluvastatin

(3S,5R)-fluvastatin(1-)

(3S,5R)FluvastatinSodiumSalt

(3S,5R,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid

(3S,5R,6E)-7-[3-(4-fluorophenyl)-1-isopropyl-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid

(6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid

(6E)-7-[3-(4-fluorophenyl)-1-isopropyl-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid

(E)-7-[3-(4-fluorophenyl)-1-propan-2-ylindol-2-yl]-3,5-dihydroxyhept-6-enoic acid

(E,3R,5S)-7-[3-(4-fluorophenyl)-1-propan-2-ylindol-2-yl]-3,5-dihydroxyhept-6-enoic acid

(E,3S,5R)-7-[3-(4-fluorophenyl)-1-propan-2-ylindol-2-yl]-3,5-dihydroxyhept-6-enoic acid

(Z,3R,5S)-7-[3-(4-fluorophenyl)-1-propan-2-ylindol-2-yl]-3,5-dihydroxyhept-6-enoic acid

stat-

6-Heptenoic acid, 7-(3-(4-fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl)- 3,5-dihydroxy-, (3R,5S,6E)-rel-

6-Heptenoic acid, 7-(3-(4-fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl)- 3,5-dihydroxy-, (R*,S*-(E))-(+-)-

6-Heptenoic acid, 7-(3-(4-fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl)-3,5-dihydroxy-, (R*,S*-(E))-(+-)-

6-Heptenoic acid, 7-[3-(4-fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl]-3,5-dihydroxy-, (3R,5S,6E)-

7-(3-(4-fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl)-3,5-dihydroxy-6-heptenoate

7-[3-(4-fluorophenyl)-1-propan-2-ylindol-2-yl]-3,5-dihydroxyhept-6-enoic acid

93957-54-1

93957-54-1; C07014; Fluvastatin

93957-54-1; D07983; Fluvas (TN); Fluvastatin (INN)

AC1L1FUW

AC1L3TXK

AC1L9J7I

AC1LU7LJ

AC1NS4EB

AC1OC9O5

AC1Q1PZO

BIDD:GT0839

BPBio1_000965

BRD-K03602135-236-02-1

BSPBio_000877

C07014

C24H26FNO4

Canef

CHEBI:38562

CHEBI:38565

CHEBI:38567

CHEBI:5136

CHEMBL1078

CHEMBL170417

CID10501876

CID146801

CID1548972

CID3403

CID446155

CID5353627

CID6914285

CID9887837

CPD001453708

Cranoc

D07983

DAP000554

DB01095

Fluindostatin

Fluindostatin; Fluvastatine [INN-French]; Fluvastatina [INN-Spanish]; Fluvastatinum [INN-Latin]

Fluindostatin;Fluvastatina [INN-Spanish];Fluvastatine [INN-French];Fluvastatinum [INN-Latin]

Fluindostatin;Fluvastatine [INN-French];Fluvastatina [INN-Spanish];Fluvastatinum [INN-Latin]

Fluvas

Fluvas (TN)

Fluvastatin & Primycin

Fluvastatin (BAN

Fluvastatin (INN)

Fluvastatin (sodium salt)

Fluvastatin Sodium

Fluvastatin sodium salt

Fluvastatin [INN:BAN]

Fluvastatina

Fluvastatina [INN-Spanish]

Fluvastatine

Fluvastatine [INN-French]

Fluvastatinum

Fluvastatinum [INN-Latin]

Fractal

HMS2089P06

I06-2297

INN); Fluvastatin Sodium (FDA

Lescol

Lescol XL

Lipaxan

Locol

LS-7404

Lymetel

MFCD00929076

MFCD08064826

MolPort-003-847-470

nchembio.301-comp9

nchembio790-comp18

Prestwick0_000859

Prestwick1_000859

Prestwick2_000859

Prestwick3_000859

Primesin

SAM002548940

Sodium; (E)-(3S,5R)-7-[3-(4-fluoro-phenyl)-1-isopropyl-1H-indol-2-yl]-3,5-dihydroxy-hept-6-enoate

SPBio_002798

T6624179

TL8005940

UNII-4L066368AS

USAN

USP)

Vastin

XU 62320

XU-62320

Download: MOL2 SDF SMILES Flexibase

Annotations

Vendors

Physical Representations

Type pH range xlogP Des A‑Pol Apolar desolvation (kcal/mol) Des Pol Polar desolvation (kcal/mol) H Don H-bond donors H Acc H-bond acceptors Chg Net charge tPSA (Ų) MWT Molecular weight (g/mol) RB Rotatable bonds DL
Ref Reference (pH 7) 4.14 11.1 -51.96 2 5 -1 86 410.465 8

Vendor Notes

Note Type Comments Provided By
ALOGPS_SOLUBILITY 4.41e-03 g/l DrugBank-approved
Patent Database Links EP0987251; EP0992496; EP1127573; EP1254667; EP1258253; EP1325745; EP1452526; EP1452530; EP1477474; EP1479666; EP1510208; EP1510521; EP1520590; EP1533292; EP1541175; EP1553091; EP1559710; EP1563837; EP1584333; EP1586644; EP1593670; EP1604686; EP1609469; EP ChEBI
mechanism Potent HMG-CoA reductase inhibitor IBScreen Bioactives
biological_use Used as an antihyperlipidaemic agent ZereneX Building Blocks
biological_use Used as an antihyperlipidaemic agent to treat hypercholesterolemia and to prevent cardiovascular disease IBScreen Bioactives

Activity (Go SEA)

Analogs ( Draw Identity 99% 90% 80% 70% )